HY
Hypera Pharma
HYPE3.SA·BVMFSao Paulo BRFounded 20016,000 employees
Mid CappharmaPublicOncologyGI
Platform: Consumer Health
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (HYPE3.SA)
Loading HYPE3.SA stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Liracapivasertib | HYP-1023 | Phase 1 | 2 | GIP-R | MCCMyelofibrosis | ||
| HYP-6536 | HYP-6536 | Preclinical | 2 | MET | MCCPBC | ||
| HYP-6990 | HYP-6990 | Preclinical | 2 | PI3Kα | RettPompe |
SEC Filings & Financial Documents
SEC filings are not available for BVMF-listed companies.
Hypera Pharma trades on BVMF (BR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)